Phibro Animal Health (PAHC) Current Leases (2019 - 2026)
Phibro Animal Health's (PAHC) quarterly Current Leases came in at $9.4 million in Q1 2026, up 4.8% year-on-year from $9.0 million in Q1 2025, and up 5.13% quarter-over-quarter from $9.0 million in Q4 2025.
Phibro Animal Health (PAHC) Current Leases (2019 - 2026) Analysis & Trends
Phibro Animal Health's Current Leases history runs 8 years deep, the most recent figure standing at $9.4 million for Q1 2026.
- On a quarterly basis, Current Leases rose 4.8% year-over-year to $9.4 million in Q1 2026; TTM through Mar 2026 was $9.4 million, a 4.8% increase from a year earlier, with the FY2025 full-year figure at $9.1 million, up 22.35% from the prior year.
- Current Leases rose to $9.4 million in Q1 2026 per PAHC's latest filing, from $9.0 million in the prior quarter.
- Across five years, Current Leases topped out at $9.4 million in Q1 2026 and bottomed at $5.7 million in Q3 2022.
- The 5-year median for Current Leases is $7.1 million (2024), against an average of $7.4 million.
- Across the five-year window, Current Leases fell 12.92% in 2022 and climbed 26.47% in 2025, its largest moves.
- Year by year, Current Leases stood at $5.7 million in 2022, then climbed by 21.83% to $7.0 million in 2023, then rose by 14.51% to $8.0 million in 2024, then increased by 11.72% to $9.0 million in 2025, then rose by 5.13% to $9.4 million in 2026.
- Per Business Quant, the three latest PAHC Current Leases figures stand at $9.4 million (Q1 2026), $9.0 million (Q4 2025), and $9.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 9.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.42 Mn |
| Dec 31, 2025 | 8.96 Mn |
| Sep 30, 2025 | 9.02 Mn |
| Jun 30, 2025 | 9.13 Mn |
| Mar 31, 2025 | 8.99 Mn |
| Dec 31, 2024 | 8.02 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.46 Mn |
| Mar 31, 2024 | 7.11 Mn |
| Dec 31, 2023 | 7.00 Mn |
| Sep 30, 2023 | 6.45 Mn |
| Jun 30, 2023 | 6.05 Mn |
| Mar 31, 2023 | 6.22 Mn |
| Dec 31, 2022 | 5.75 Mn |
| Sep 30, 2022 | 5.67 Mn |
| Jun 30, 2022 | 6.05 Mn |
| Mar 31, 2022 | 6.43 Mn |
| Dec 31, 2021 | 6.60 Mn |
| Sep 30, 2021 | 6.41 Mn |
| Jun 30, 2021 | 6.62 Mn |